SMG1 and gastric cancer: Based on the findings in our study, the SMG1-UPF mRNA decay pathway and miR-3658 silencing are two independent posttranscriptional regulatory mechanisms underlying the inhibitory effect of GLA on gastric cancer cells, and they have an additive effect of enabling the desired anti-cancer effect of GLA.